Evidence map›Paper›PMID 42209935›Full record

ArticleJournal of community genetics2026

51st annual meeting of ICBDSR: data that counts - transforming lives through birth defects surveillance.

H Malherbe, E Kalk, L D Botto, C Mellado, M A Thomas, A Rissmann

Abstract read
In one paragraph

Article in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

H MalherbeCentre for Human Metabolomics, Desmond Tutu School of Medicine, Faculty of Health Sciences, North West University, 11 Hoffmann Street, Potchefstroom, 2531, South Africa. Helen.malherbe@nwu.ac.za.ORCID http://orcid.org/0000-0002-9566-6248
E KalkCentre for Integrated Data & Epidemiological Research, School of Public Health, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0001-7706-6866
L D BottoInternational Center on Birth Defects and Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0002-5322-7116
C MelladoSection of Genetics and Inborn Errors of Metabolism, School of Medicine, Universidad Católica de Chile, Santiago, Chile.ORCID http://orcid.org/0000-0002-6032-4651
M A ThomasDepartments of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0009-0006-8855-7445
A RissmannMedical Faculty, Malformation Monitoring Centre Saxony-Anhalt, Otto-Von- Guericke-University , Magdeburg, Germany.ORCID http://orcid.org/0000-0002-9437-2790

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 51st Annual Meeting of the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) was held from 2 to 5 November 2025 in Magaliesburg, South Africa. The meeting brought together clinicians, epidemiologists, public health practitioners and researchers from 24 countries to discuss advances in the surveillance, prevention, and management of birth defects. Hosting the meeting in South Africa reflected a strategic effort to strengthen engagement with low- and middle-income countries and to expand African participation in global birth defects surveillance initiatives. Scientific sessions addressed methodological developments in surveillance systems, etiological research, and approaches to improving the interpretation and communication of surveillance data for policy and public health action. Emphasis was placed on strengthening data quality, harmonising case definitions and reporting practices across registries, and building technical capacity in emerging surveillance programmes. Contributions from African researchers highlighted both the challenges and opportunities associated with implementing surveillance in resource-constrained settings. The meeting underscored the importance of international collaboration, inclusive surveillance networks, and effective translation of data into prevention strategies and health system planning. Strengthening global surveillance remains essential for informing prevention efforts and improving outcomes for children and families affected by birth defects.

Indexed as

Birth defect surveillanceCongenital anomaly registriesData harmonisationGlobal surveillance networksSub-Saharan Africa

Identifiers

PMID42209935
PMCPMC13219656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.